All

Wesper Demos Two Levels of Sleep Testing (in One Ecosystem)

The new platform integrates Wesper Lab and Wesper Lite to offer customized diagnostic pathways and streamline patient management for sleep clinics.

All

Resmed, Oura Partner to Connect Wearable Sleep Data with Clinical Care Pathways

The collaboration aims to close the sleep apnea awareness gap by directing Oura Ring users with nighttime breathing disturbances to Resmed’s educational and clinical resources.

All

FDA Grants Breakthrough Device Designation to Sleep Sonar for Anatomic PSG

Bairitone Health's platform uses passive sleep sonar and a facial patch to map airway anatomy during natural sleep, aiming to pinpoint the root causes of obstruction and guide personalized therapy.

Nihon Kohden Expands NomadAir with Connect into Dental Sleep Medicine

May 5, 2026 | Home Apnea Testing

The HST aims to improve collaboration between dentists and sleep physicians by offering real-time data visibility.

What Makes a ‘Quiet’ CPAP Mask?

Apr 27, 2026 | CPAP & PAP Devices

How CPAP mask acoustics have improved to facilitate better sleep for the patient and the oft-overlooked bed partner.

Machine Learning Model Predicts CPAP Impact on Cardiovascular Risk in OSA

Apr 23, 2026 | CPAP & PAP Devices, Heart

Mount Sinai researchers developed an analytic tool that estimates individualized cardiovascular outcomes for obstructive sleep apnea patients using CPAP therapy.

OpenLoop Expands Into Sleep Diagnostics With Happy Sleep Partnership

Apr 22, 2026 | Home Apnea Testing

The telehealth platform is adding at-home sleep apnea testing via the FDA-cleared Happy Ring to help close the gap in OSA diagnosis and care.

12-Month Results from LivaNova’s OSPREY Clinical Study Published

Apr 21, 2026 | Neurostimulators

Full data set demonstrates proximal hypoglossal nerve stimulation yields clinically significant and sustained improvements for patients with moderate to severe OSA.

Vivos Reports 16% Revenue Increase in 2025 Following Business Model Shift

Apr 21, 2026 | Oral Appliances

The medical device company’s new strategy focuses on acquiring and partnering with sleep specialty medical providers, driving revenue growth and a path toward positive cash flow.

Apnimed Secures Up to $150 Million to Support Planned Commercial Launch of AD109

Apr 7, 2026 | Emerging Compounds, Financial, Obstructive Sleep Apnea

The financing will fund commercial readiness for the investigational oral obstructive sleep apnea therapy ahead of an anticipated new drug application.

Study Links High Night-to-Night Variability in OSA to Accelerated Vascular Aging

Apr 2, 2026 | Mattress-Based Sleep Trackers, Obstructive Sleep Apnea

Real-world data from nearly 30,000 adults suggest single-night assessments may underestimate cardiovascular risks associated with sleep-disordered breathing.

Vivos Therapeutics’ Supported Practices Achieve In-Network Status in Nevada

Mar 31, 2026 | Medicare & Medicaid, Oral Appliances

Physician-owned practices supported by Vivos in Nevada are now in-network with major commercial insurers and Medicare, expanding patient access to its sleep apnea treatments.

FDA Approves Expanded MRI Compatibility for Inspire IV and V

Mar 27, 2026 | Neurostimulators

The expanded clearance allows patients with moderate to severe obstructive sleep apnea using the latest Inspire implants to undergo high-resolution 3.0 Tesla MRI scans under specified conditions.

Philips Meets Requirements to Offer DreamStation BiPAP AVAPS for Lower-Weight Patients

Mar 23, 2026 | CPAP & PAP Devices

The devices are designated as medically necessary for a limited patient population older than 7 years and weighing 40 to 66 lbs who have obstructive sleep apnea and respiratory impairment.

Saline Nasal Spray Shows Efficacy in Treating Pediatric Sleep-Disordered Breathing

Mar 20, 2026 | Over-the-Counter Treatments

A new Australian study finds that a simple saline nasal spray can resolve symptoms of obstructive sleep-disordered breathing in children, potentially reducing the need for surgery and specialist care.

Yes, GLP-1s Treat (Some) OSA, But They Also Expose Limits of Obesity-Focused Strategies

Mar 19, 2026 | Obstructive Sleep Apnea, Prescription Drugs

As weight-linked cases improve, the field is left to confront the patients whose condition stems from other mechanisms.

Sunrise HST Tested Against PSG

Mar 19, 2026 | Home Apnea Testing

The trial, which enrolled 849 adults across 18 sleep centers in France, directly compares the two diagnostic pathways in routine clinical practice.

Hospital Increases Sleep Testing Capacity by 290% With Dropship Model

Mar 18, 2026 | Home Apnea Testing

The transition from in-office device pickup to a direct-to-patient model via Wesper eliminated the backlog and enabled multi-night studies and at-home CPAP titration.

Tag: OSA

All

All

All